| __timestamp | Dr. Reddy's Laboratories Limited | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12402000000 | 11768000 |
| Thursday, January 1, 2015 | 17449000000 | 15152000 |
| Friday, January 1, 2016 | 17834000000 | 19828000 |
| Sunday, January 1, 2017 | 19551000000 | 25573000 |
| Monday, January 1, 2018 | 18265000000 | 23634000 |
| Tuesday, January 1, 2019 | 15607000000 | 38845000 |
| Wednesday, January 1, 2020 | 15410000000 | 50523000 |
| Friday, January 1, 2021 | 16541000000 | 75463000 |
| Saturday, January 1, 2022 | 17482000000 | 105767000 |
| Sunday, January 1, 2023 | 19381000000 | 167512000 |
| Monday, January 1, 2024 | 22873000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Dr. Reddy's Laboratories Limited, a major player in the global pharmaceutical market, has consistently invested heavily in R&D over the past decade. From 2014 to 2023, their R&D expenses have grown by approximately 85%, peaking in 2024. In contrast, Xenon Pharmaceuticals Inc., a smaller biotech firm, has shown a remarkable increase in R&D spending, with a growth of over 1,300% from 2014 to 2023. This stark difference highlights the diverse strategies employed by large and small companies in the pharmaceutical sector. While Dr. Reddy's focuses on steady, substantial investments, Xenon Pharmaceuticals is rapidly scaling its innovation efforts. However, data for 2024 is missing for Xenon, indicating potential reporting delays or strategic shifts.
R&D Spending Showdown: Amgen Inc. vs Xenon Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Axsome Therapeutics, Inc.
R&D Spending Showdown: Dr. Reddy's Laboratories Limited vs Verona Pharma plc
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Ultragenyx Pharmaceutical Inc.
R&D Insights: How Dr. Reddy's Laboratories Limited and Galapagos NV Allocate Funds
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Novavax, Inc.
Analyzing R&D Budgets: Exelixis, Inc. vs Xenon Pharmaceuticals Inc.
R&D Insights: How Ultragenyx Pharmaceutical Inc. and Xenon Pharmaceuticals Inc. Allocate Funds
R&D Insights: How Apellis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc. Allocate Funds
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
Comparing Innovation Spending: Xenon Pharmaceuticals Inc. and Novavax, Inc.